Feasibility of Laparoscopic Re‐resection for Patients with Recurrent Hepatocellular Carcinoma

医学 围手术期 肝细胞癌 外科 心胸外科 血管外科 腹部外科 失血 腹腔镜检查 腹腔镜手术 人口统计学的 肝切除术 切除术 心脏外科 普通外科 内科学 人口学 社会学
作者
Albert Chan,Ronnie T.P. Poon,Ksh Chok,Tan To Cheung,See Ching Chan,Chung Mau Lo
出处
期刊:World Journal of Surgery [Springer Science+Business Media]
卷期号:38 (5): 1141-1146 被引量:49
标识
DOI:10.1007/s00268-013-2380-3
摘要

Abstract Background Repeated resection via an open approach is an effective treatment for post‐operative recurrent hepatocellular carcinoma (HCC). However, there are limited data on the application of laparoscopic approach for recurrent HCC in patients with prior liver resections. The aim of this study was to review our experience of laparoscopic re‐resection in patients with postoperative tumor recurrence. Materials and methods A total of 11 patients received laparoscopic re‐resections for postoperative tumor recurrence in our center. Data were reviewed for demographics, tumor characteristics, and perioperative outcomes. Case‐match analysis with the open approach was performed in a 1:2 ratio. Results Six patients had their first liver resection carried out via the open approach and the remaining five patients received the laparoscopic approach. The recurrent tumor size was 20 mm (12–50 mm) and ten patients had a solitary recurrence. Two patients had laparoscopic left lateral sectionectomy and the remaining nine patients had sub‐segmentectomies. There was no significant difference in patient characteristics, preoperative liver function, and tumor features between the laparoscopic and open groups. Perioperative blood loss was significantly reduced in the laparoscopic group (100 vs. 314 mL; p = 0.014) but the morbidity rate (18.2 vs. 4.5 %; p = 0.199) and length of hospitalization were comparable (6 vs. 5 days; p = 0.831). The 3‐year overall survival rates for the laparoscopic and open groups were 60.0 and 89.3 %, respectively ( p = 0.279). Conclusion Our study showed that laparoscopic re‐resection for recurrent HCC was feasible with satisfactory postoperative and oncological outcomes, even in patients with previous major liver resections.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阔达听寒完成签到,获得积分10
1秒前
1秒前
周先森完成签到,获得积分10
1秒前
1秒前
1秒前
LB发布了新的文献求助10
2秒前
Copyright应助失眠的契采纳,获得10
2秒前
凉月发布了新的文献求助10
2秒前
翟老师完成签到,获得积分10
2秒前
核桃nut完成签到,获得积分10
3秒前
wind完成签到 ,获得积分10
3秒前
和谐的小懒虫完成签到,获得积分10
4秒前
欣喜访文完成签到,获得积分10
4秒前
彼得潘同学完成签到,获得积分10
5秒前
hx完成签到 ,获得积分10
5秒前
5秒前
吉不二完成签到,获得积分10
5秒前
硕高居胜完成签到,获得积分10
6秒前
超帅向雁发布了新的文献求助10
6秒前
如花不如画完成签到 ,获得积分10
6秒前
YY完成签到,获得积分10
6秒前
7秒前
科研通AI6.3应助欣喜访文采纳,获得10
7秒前
cym完成签到,获得积分10
7秒前
迷途完成签到,获得积分10
7秒前
谦让的晟睿完成签到 ,获得积分10
7秒前
廖紊完成签到,获得积分10
8秒前
无情白羊完成签到,获得积分10
8秒前
罗思源完成签到 ,获得积分10
8秒前
栗子发布了新的文献求助10
8秒前
huokuoluo完成签到,获得积分10
8秒前
科研小垃圾完成签到,获得积分0
9秒前
tigger发布了新的文献求助20
10秒前
村雨完成签到,获得积分10
10秒前
喜悦的梦露完成签到,获得积分10
11秒前
丘比特应助辛勤冬天采纳,获得10
11秒前
Tong完成签到,获得积分10
11秒前
11秒前
风之飘渺者也完成签到,获得积分10
12秒前
ZJJ静完成签到,获得积分10
12秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Molecular Mechanisms of Photosynthesis, 4th Edition 1000
Organic Reactions, Volume 116 1000
Matrix Methods in Data Mining and Pattern Recognition 510
Social Skills Improvement System-Rating Scales--Chinese Version 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7253008
求助须知:如何正确求助?哪些是违规求助? 8875175
关于积分的说明 18735271
捐赠科研通 6933598
什么是DOI,文献DOI怎么找? 3199840
关于科研通互助平台的介绍 2374606
邀请新用户注册赠送积分活动 2174506